Hypersensitivity-v1.0(2022EN): verschil tussen versies

Uit Zorginformatiebouwstenen
Naar navigatie springen Naar zoeken springen
(Nieuwe pagina aangemaakt met '<!-- Hieronder wordt een transclude page aangeroepen --> {{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.8.4(EN)|1|Hypersensitivity-v1.0(2022EN)}} <!-- Tot hier de...')
 
Geen bewerkingssamenvatting
 
(3 tussenliggende versies door dezelfde gebruiker niet weergegeven)
Regel 8: Regel 8:
Release<!--hdPublication-->: '''2022''' <br>
Release<!--hdPublication-->: '''2022''' <br>
Release status<!--hdPublicationStatus-->: Prepublished<br>
Release status<!--hdPublicationStatus-->: Prepublished<br>
Release date<!--hdPublicationDate-->: 10-06-2022
Release date<!--hdPublicationDate-->: 15-10-2023
<!-- Aanroep Errata transclude page -->
<!-- Aanroep Errata transclude page -->
{{ErrataEN<!--hdErrata-->|2022|{{PAGENAME}}}}
{{ErrataEN<!--hdErrata-->|2022|{{PAGENAME}}}}
Regel 50: Regel 50:
|style="width:250px; "|DCM::Name||nl.zorg.Overgevoeligheid
|style="width:250px; "|DCM::Name||nl.zorg.Overgevoeligheid
|-  
|-  
|style="width:250px; "|DCM::PublicationDate||10-06-2022
|style="width:250px; "|DCM::PublicationDate||15-10-2023
|-  
|-  
|style="width:250px; "|DCM::PublicationStatus||Prepublished
|style="width:250px; "|DCM::PublicationStatus||Prepublished
Regel 93: Regel 93:
rect 670 338 786 407 [[HealthProfessional-v3.5.2(2022EN)]]
rect 670 338 786 407 [[HealthProfessional-v3.5.2(2022EN)]]
rect 852 436 997 486 [[#WayOfDeterminationCodelist]]
rect 852 436 997 486 [[#WayOfDeterminationCodelist]]
rect 670 515 786 585 [[#14683]]
rect 670 515 786 585 [[#2357]]
rect 670 425 786 495 [[#14676]]
rect 670 425 786 495 [[#2350]]
rect 670 160 786 228 [[#14668]]
rect 670 160 786 228 [[#2329]]
rect 531 156 621 226 [[#14677]]
rect 531 156 621 226 [[#2351]]
rect 298 707 536 745 [[#AgentHPKCodelist]]
rect 298 707 536 745 [[#AgentHPKCodelist]]
rect 318 658 564 696 [[#AgentAllergicAgentCodelist]]
rect 318 658 564 696 [[#AgentAllergicAgentCodelist]]
Regel 102: Regel 102:
rect 35 608 238 646 [[#AgentSNKCodelist]]
rect 35 608 238 646 [[#AgentSNKCodelist]]
rect 50 659 261 697 [[#AgentSSKCodelist]]
rect 50 659 261 697 [[#AgentSSKCodelist]]
rect 374 154 486 224 [[#14675]]
rect 374 154 486 224 [[#2349]]
rect 224 156 354 226 [[#14673]]
rect 224 156 354 226 [[#2347]]
rect 224 336 354 406 [[#14689]]
rect 224 336 354 406 [[#2363]]
rect 416 608 575 646 [[#HypersensitivityStatusCodelist]]
rect 416 608 575 646 [[#HypersensitivityStatusCodelist]]
rect 37 441 210 479 [[#HypersensitivityCategoryCodelist]]
rect 37 441 210 479 [[#HypersensitivityCategoryCodelist]]
rect 37 354 196 392 [[#CriticalExtentCodelist]]
rect 37 354 196 392 [[#CriticalExtentCodelist]]
rect 431 515 543 585 [[#14682]]
rect 431 515 543 585 [[#2356]]
rect 224 426 354 496 [[#14687]]
rect 224 426 354 496 [[#2361]]
rect 224 515 354 585 [[#14686]]
rect 224 515 354 585 [[#2360]]
rect 225 246 355 316 [[#14685]]
rect 225 246 355 316 [[#2359]]
rect 432 309 542 379 [[#14674]]
rect 432 309 542 379 [[#2348]]
desc none
desc none
</imagemap>
</imagemap>
Regel 122: Regel 122:
|style = "text-align:center" |[[Bestand: block.png| 20px | link=]]
|style = "text-align:center" |[[Bestand: block.png| 20px | link=]]
||NL-CM:8.4.1
||NL-CM:8.4.1
|colspan ="6" style ="padding-left: 0px"|<span Id=14674 Title="NL: Overgevoeligheid">[[Bestand: arrowdown.png | 10px | link=]]Hypersensitivity</span>
|colspan ="6" style ="padding-left: 0px"|<span Id=2348 Title="NL: Overgevoeligheid">[[Bestand: arrowdown.png | 10px | link=]]Hypersensitivity</span>
|
|
|Root concept of the Hypersensitivity information model. This root concept contains all data elements of the Hypersensitivity information model.
|Root concept of the Hypersensitivity information model. This root concept contains all data elements of the Hypersensitivity information model.
Regel 131: Regel 131:
||NL-CM:8.4.2
||NL-CM:8.4.2
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|<span Id=14680 Title="NL: Reactie">[[Bestand: arrowright.png | 10px | link=]]Reaction</span>
|colspan ="5" style ="padding-left: 0px"|<span Id=2354 Title="NL: Reactie">[[Bestand: arrowright.png | 10px | link=]]Reaction</span>
|0..*
|0..*
|Root concept of the Reaction information model. This root concept contains all data elements of the Reaction information model.
|Root concept of the Reaction information model. This root concept contains all data elements of the Reaction information model.
Regel 144: Regel 144:
||NL-CM:8.4.3
||NL-CM:8.4.3
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|<span Id=14668 Title="NL: DatumTijdAfsluiten">[[Bestand: arrowright.png | 10px | link=]]DateTimeClosure</span>
|colspan ="5" style ="padding-left: 0px"|<span Id=2329 Title="NL: DatumTijdAfsluiten">[[Bestand: arrowright.png | 10px | link=]]DateTimeClosure</span>
|0..1
|0..1
|The date and time when it was decided to stop monitoring.​
|The date and time when it was decided to stop monitoring.​
Regel 153: Regel 153:
||NL-CM:8.4.4
||NL-CM:8.4.4
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|<span Id=14670 Title="NL: EersteAuteur::Zorgverlener">[[Bestand: arrowright.png | 10px | link=]]FirstAuthor::HealthProfessional</span>
|colspan ="5" style ="padding-left: 0px"|<span Id=2344 Title="NL: EersteAuteur::Zorgverlener">[[Bestand: arrowright.png | 10px | link=]]FirstAuthor::HealthProfessional</span>
|1
|1
|The healthcare professional who first started monitoring the hypersensitivity.
|The healthcare professional who first started monitoring the hypersensitivity.
Regel 166: Regel 166:
||NL-CM:8.4.5
||NL-CM:8.4.5
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|<span Id=14676 Title="NL: ManierVanVastellen">[[Bestand: arrowright.png | 10px | link=]]WayOfDetermination</span>
|colspan ="5" style ="padding-left: 0px"|<span Id=2350 Title="NL: ManierVanVastellen">[[Bestand: arrowright.png | 10px | link=]]WayOfDetermination</span>
|0..1
|0..1
|The way in which the hypersensitivity is determined.
|The way in which the hypersensitivity is determined.
Regel 179: Regel 179:
||NL-CM:8.4.6
||NL-CM:8.4.6
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|<span Id=14683 Title="NL: OmschrijvingBron">[[Bestand: arrowright.png | 10px | link=]]SourceDescription</span>
|colspan ="5" style ="padding-left: 0px"|<span Id=2357 Title="NL: OmschrijvingBron">[[Bestand: arrowright.png | 10px | link=]]SourceDescription</span>
|0..1
|0..1
|The description of how the information was obtained, such as receiving a letter from a specialist or an interview with the patient.
|The description of how the information was obtained, such as receiving a letter from a specialist or an interview with the patient.
Regel 188: Regel 188:
||NL-CM:8.4.7
||NL-CM:8.4.7
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|<span Id=14677 Title="NL: RedenVanAfsluiten">[[Bestand: arrowright.png | 10px | link=]]ReasonForClosure</span>
|colspan ="5" style ="padding-left: 0px"|<span Id=2351 Title="NL: RedenVanAfsluiten">[[Bestand: arrowright.png | 10px | link=]]ReasonForClosure</span>
|0..1
|0..1
|Reason why the hypersensitivity is closed.
|Reason why the hypersensitivity is closed.
Regel 197: Regel 197:
||NL-CM:8.4.8
||NL-CM:8.4.8
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|<span Id=14686 Title="NL: Stof">[[Bestand: arrowright.png | 10px | link=]]Agent</span>
|colspan ="5" style ="padding-left: 0px"|<span Id=2360 Title="NL: Stof">[[Bestand: arrowright.png | 10px | link=]]Agent</span>
|1
|1
|The substance or group of substances that is monitored.
|The substance or group of substances that is monitored.
Regel 218: Regel 218:
||NL-CM:8.4.9
||NL-CM:8.4.9
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|<span Id=14687 Title="NL: OvergevoeligheidCategorie">[[Bestand: arrowright.png | 10px | link=]]HypersensitivityCategory</span>
|colspan ="5" style ="padding-left: 0px"|<span Id=2361 Title="NL: OvergevoeligheidCategorie">[[Bestand: arrowright.png | 10px | link=]]HypersensitivityCategory</span>
|0..*
|0..*
|Identifies the hypersensitivity category such as medication, food or environment.
|Identifies the hypersensitivity category such as medication, food or environment.
Regel 231: Regel 231:
||NL-CM:8.4.10
||NL-CM:8.4.10
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|<span Id=14682 Title="NL: OvergevoeligheidStatus">[[Bestand: arrowright.png | 10px | link=]]HypersensitivityStatus</span>
|colspan ="5" style ="padding-left: 0px"|<span Id=2356 Title="NL: OvergevoeligheidStatus">[[Bestand: arrowright.png | 10px | link=]]HypersensitivityStatus</span>
|0..1
|0..1
|Statement on the status of the patient’s hypersensitivity.
|Statement on the status of the patient’s hypersensitivity.
Regel 244: Regel 244:
||NL-CM:8.4.11
||NL-CM:8.4.11
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|<span Id=14685 Title="NL: BeginDatumTijd">[[Bestand: arrowright.png | 10px | link=]]StartDateTime</span>
|colspan ="5" style ="padding-left: 0px"|<span Id=2359 Title="NL: BeginDatumTijd">[[Bestand: arrowright.png | 10px | link=]]StartDateTime</span>
|0..1
|0..1
|Date and time when the hypersensitivity first manifested itself in a reaction. This can be an exact date and time, but also a global indication of the date (for example, only year or year and month).
|Date and time when the hypersensitivity first manifested itself in a reaction. This can be an exact date and time, but also a global indication of the date (for example, only year or year and month).
Regel 254: Regel 254:
||NL-CM:8.4.12
||NL-CM:8.4.12
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|<span Id=14689 Title="NL: RisicoBeoordeling">[[Bestand: arrowright.png | 10px | link=]]Criticality</span>
|colspan ="5" style ="padding-left: 0px"|<span Id=2363 Title="NL: RisicoBeoordeling">[[Bestand: arrowright.png | 10px | link=]]Criticality</span>
|1
|1
|The healthcare professional's assessment of whether the hypersensitivity is a contraindication to intended or unintended exposure to the substance, group of substances or environmental factor to which the patient is hypersensitive.
|The healthcare professional&#39;s assessment of whether the hypersensitivity is a contraindication to intended or unintended exposure to the substance, group of substances or environmental factor to which the patient is hypersensitive.
|
|
{|
{|
Regel 271: Regel 271:
||NL-CM:8.4.13
||NL-CM:8.4.13
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|<span Id=14673 Title="NL: StartBewakingDatumTijd">[[Bestand: arrowright.png | 10px | link=]]StartSurveillanceDateTime</span>
|colspan ="5" style ="padding-left: 0px"|<span Id=2347 Title="NL: StartBewakingDatumTijd">[[Bestand: arrowright.png | 10px | link=]]StartSurveillanceDateTime</span>
|1
|1
|Date and time when the first author started monitoring the hypersensitivity.
|Date and time when the first author started monitoring the hypersensitivity.
Regel 280: Regel 280:
||NL-CM:8.4.14
||NL-CM:8.4.14
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|<span Id=14675 Title="NL: Toelichting">[[Bestand: arrowright.png | 10px | link=]]Comment</span>
|colspan ="5" style ="padding-left: 0px"|<span Id=2349 Title="NL: Toelichting">[[Bestand: arrowright.png | 10px | link=]]Comment</span>
|0..1
|0..1
|Textual explanation of the hypersensitivity which cannot be entered in any of the other fields.
|Textual explanation of the hypersensitivity which cannot be entered in any of the other fields.
Regel 286: Regel 286:
{|
{|
|-
|-
|<span title = "Codesystem: LOINC (Nar)" >[https://terminologie.nictiz.nl/art-decor/loinc?conceptId=48767-8 48767-8] Annotation comment [Interpretation] Narrative</span>
|<span title = "Codesystem: LOINC; Verklarend commentaar [interpretatie] in {systeem} (Nar)" >[https://terminologie.nictiz.nl/art-decor/loinc?conceptId=48767-8 48767-8] Annotation comment [Interpretation] Narrative</span>
|}
|}
|
|
Regel 296: Regel 296:
''Only available in Dutch<!--noTranslation-->''
''Only available in Dutch<!--noTranslation-->''


{|class="wikitable" width="759px" style= "font-size: 9.5pt;"
Voorbeeld file fout: Unable to find the specified file. : nl.zorg.Overgevoeligheid-v1.0(NL)_Voorbeeld.docx
|-style=vertical-align:top;
|colspan="3" style="background-color: #004080; width: 100%; "|<font color=White><b>Overgevoeligheid</b></font>
|-style=vertical-align:top;
| style="width: 30%; "|<b>Stof</b><b> </b>
| style="width: 27%; "|Amoxicilline/clavulaanzuur
| style="width: 43%; "|Penicillines
|-style=vertical-align:top;
| style="width: 30%; "|<b>Overgevoeligheidscategorie</b>
| style="width: 27%; "|Geneesmiddelen
| style="width: 43%; "|Geneesmiddelen
|-style=vertical-align:top;
|colspan="3" style="background-color: #4F81BD; width: 100%; "|<font color=White><b>EersteAuteur</b></font><font color=White><b>::Zorgverlener</b></font>
|-style=vertical-align:top;
| style="width: 30%; "|<b>Naam</b>
| style="width: 27%; "|Mevr. Zaal
| style="width: 43%; "|Mevr. Zaal
|-style=vertical-align:top;
| style="width: 30%; "|<b>Specialisme</b>
| style="width: 27%; "|SEH-arts
| style="width: 43%; "|SEH-arts
|-style=vertical-align:top;
|colspan="3" style="background-color: #2E74B5; width: 100%; "|
|-style=vertical-align:top;
| style="width: 30%; "|<b>Risicobeoordeling</b><b> </b>
| style="width: 27%; "|Laag
| style="width: 43%; "|Ernstig
|-style=vertical-align:top;
| style="width: 30%; "|<b>Manier van vast stellen</b>
| style="width: 27%; "|Vastgesteld op basis van het klinisch beeld
| style="width: 43%; "|Op basis van anamnese
|-style=vertical-align:top;
| style="width: 30%; "|<b>Omschrijving van de bron</b>
| style="width: 27%; "|Gesprek met patiënt
| style="width: 43%; "|<noWiki>-</noWiki>
|-style=vertical-align:top;
| style="width: 30%; "|<b>Toelichting</b>
| style="width: 27%; "|<noWiki>-</noWiki>
| style="width: 43%; "|<noWiki>-</noWiki>
|-style=vertical-align:top;
| style="width: 30%; "|<b>Begindatumtijd</b>
| style="width: 27%; "|25-10-2021
| style="width: 43%; "|25-10-2021
|-style=vertical-align:top;
| style="width: 30%; "|<b>Startbewakingdatumtijd</b>
| style="width: 27%; "|25-10-2021
| style="width: 43%; "|25-10-2021
|-style=vertical-align:top;
| style="width: 30%; "|<b>Datum van afsluiten</b>
| style="width: 27%; "|<noWiki>-</noWiki>
| style="width: 43%; "|<noWiki>-</noWiki>
|-style=vertical-align:top;
| style="width: 30%; "|<b>Overgevoeligheidstatus</b>
| style="width: 27%; "|Actief
| style="width: 43%; "|Actief
|-style=vertical-align:top;
|colspan="3" style="background-color: #4F81BD; width: 100%; "|<font color=White><b>Reactie</b></font>
|-style=vertical-align:top;
| style="width: 30%; "|<b>ReactieErnst</b>
| style="width: 27%; "|Ernstig
| style="width: 43%; "|Matig
|-style=vertical-align:top;
| style="width: 30%; "|<b>ReactieTijdstip</b>
| style="width: 27%; "|12-10-2020
| style="width: 43%; "|02-06-2021
|-style=vertical-align:top;
| style="width: 30%; "|<b>ReactieSymptomen</b>
| style="width: 27%; "|Trombocytopenie
| style="width: 43%; "|Jeuk
|-style=vertical-align:top;
| style="width: 30%; "|<b>Veroorzakendestof</b>
| style="width: 27%; "|Amoxicilline/clavulaanzuur
| style="width: 43%; "|Penicillines
|-style=vertical-align:top;
| style="width: 30%; "|
| style="width: 27%; "|
| style="width: 43%; "|
|}
 
==Issues==
==Issues==
<b>No known allergies</b>
<b>No known allergies</b>
Regel 414: Regel 336:
|Codesystem name<!--vsConceptSystemName-->||Codesystem OID<!--vsConceptSystemOID-->
|Codesystem name<!--vsConceptSystemName-->||Codesystem OID<!--vsConceptSystemOID-->
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|Alle waarden
|All values
|G-Standaard Handels Product Kode (HPK)
|G-Standaard Handels Product Kode (HPK)
|2.16.840.1.113883.2.4.4.7
|2.16.840.1.113883.2.4.4.7
Regel 429: Regel 351:
|Codesystem name<!--vsConceptSystemName-->||Codesystem OID<!--vsConceptSystemOID-->
|Codesystem name<!--vsConceptSystemName-->||Codesystem OID<!--vsConceptSystemOID-->
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|Alle waarden
|All values
|G-standaard Stofnaamcode (SNK)
|G-standaard Stofnaamcode (SNK)
|2.16.840.1.113883.2.4.4.1.750
|2.16.840.1.113883.2.4.4.1.750
Regel 444: Regel 366:
|Codesystem name<!--vsConceptSystemName-->||Codesystem OID<!--vsConceptSystemOID-->
|Codesystem name<!--vsConceptSystemName-->||Codesystem OID<!--vsConceptSystemOID-->
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|Alle waarden
|All values
|G-standaard Stofnaamcode i.c.m. toedieningsweg (SSK)
|G-standaard Stofnaamcode i.c.m. toedieningsweg (SSK)
|2.16.840.1.113883.2.4.4.1.725
|2.16.840.1.113883.2.4.4.1.725
Regel 459: Regel 381:
|Codesystem name<!--vsConceptSystemName-->||Codesystem OID<!--vsConceptSystemOID-->
|Codesystem name<!--vsConceptSystemName-->||Codesystem OID<!--vsConceptSystemOID-->
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|Alle waarden
|All values
|G-standaard Ongewenste medicatiegroepen
|G-standaard Ongewenste medicatiegroepen
|2.16.840.1.113883.2.4.4.1.902.122
|2.16.840.1.113883.2.4.4.1.902.122
Regel 611: Regel 533:
:--
:--
==Technical specifications in HL7v3 CDA and HL7 FHIR<!--ftHeader-->==
==Technical specifications in HL7v3 CDA and HL7 FHIR<!--ftHeader-->==
To exchange information based on health and care information models, additional, more technical specifications are required.<BR>
To exchange information based on health and care information models, additional, more technical specifications are required.&lt;BR&gt;
Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:<!--ftReferenceIntro-->
Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:<!--ftReferenceIntro-->
<ul>
<ul>
<li>HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment<!--ftArtDecorReference--> {{ArtDecorLinks|2022|8.4}}</li>
<li>HL7&#174; version 3 CDA compatible specifications, available through the Nictiz ART-DECOR&#174; environment<!--ftArtDecorReference--> {{ArtDecorLinks|2022|8.4}}</li>
<li>HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR<!--ftSimplifierReference--> {{SimplefierLinks|2022}}</li>
<li>HL7&#174; FHIR&#174; compatible specifications, available through the Nictiz environment on the Simplifier FHIR<!--ftSimplifierReference--> {{SimplefierLinks|2022|Overgevoeligheid}}</li>
</ul>
</ul>
==Downloads<!--ftDownloadTitle-->==
==Downloads<!--ftDownloadTitle-->==
Regel 623: Regel 545:
SNOMED CT and LOINC codes are based on:
SNOMED CT and LOINC codes are based on:
<ul>
<ul>
<li>SNOMED Clinical Terms version: 20220131 [R] (January 2022 Release)</li>
<li>SNOMED Clinical Terms versie: 20230930 [R] (september 2023-editie)</li>
<li>LOINC version 2.67</li>
<li>LOINC version 2.76</li>
</ul>
</ul>
Conditions for use are located on the mainpage<!--ftConditions--> [[Bestand:list2.png|link=HCIM_Mainpage<!--wikiMainpage-->]]<BR>
Conditions for use are located on the mainpage<!--ftConditions--> [[Bestand:list2.png|link=HCIM_Mainpage<!--wikiMainpage-->]]<BR>
This page is generated on 10/06/2022 12:43:21 with ZibExtraction v. 8.0.8196.20371<!--ftDate--> <BR>
This page is generated on 27/03/2024 11:10:39 with ZibExtraction v. 9.3.8851.20230<!--ftDate--> <BR>
-----
-----
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release<!--wikiReleasePage-->_2022(EN)]] [[HCIM_Release<!--wikiReleasePage-->_2022(EN) |Back to HCIM list<!--hdBackToMainPage--> ]]</div>
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release<!--wikiReleasePage-->_2022(EN)]] [[HCIM_Release<!--wikiReleasePage-->_2022(EN) |Back to HCIM list<!--hdBackToMainPage--> ]]</div>

Huidige versie van 27 mrt 2024 om 10:24



General information

Name: nl.zorg.Hypersensitivity NL.png
Version: 1.0
HCIM Status:Final
Release: 2022
Release status: Prepublished
Release date: 15-10-2023

Back 16.png Back to HCIM list

Metadata

DCM::CoderList Werkgroep Overgevoeligheid
DCM::ContactInformation.Address *
DCM::ContactInformation.Name *
DCM::ContactInformation.Telecom *
DCM::ContentAuthorList Werkgroep Overgevoeligheid
DCM::CreationDate 4-10-2021
DCM::DeprecatedDate
DCM::DescriptionLanguage nl
DCM::EndorsingAuthority.Address
DCM::EndorsingAuthority.Name PM
DCM::EndorsingAuthority.Telecom
DCM::Id 2.16.840.1.113883.2.4.3.11.60.40.3.8.4
DCM::KeywordList Allergie,Overgevoeligheid
DCM::LifecycleStatus Final
DCM::ModelerList Werkgroep Overgevoeligheid
DCM::Name nl.zorg.Overgevoeligheid
DCM::PublicationDate 15-10-2023
DCM::PublicationStatus Prepublished
DCM::ReviewerList Werkgroep Overgevoeligheid
DCM::RevisionDate
DCM::Supersedes
DCM::Version 1.0
HCIM::PublicationLanguage EN

Revision History

Only available in Dutch

Publicatieversie 1.0 (01-12-2021) .

Concept

A hypersensitivity describes a substance or group of substances that is monitored so that a hypersensitivity reaction can be prevented.

Purpose

  • A drug hypersensitivity is recorded so that prescribers, providers and administrators can take it into account when prescribing, dispensing and administering medication. It is recorded in such a way that a medication monitoring system can give a warning at the right time. Other sensitivities such as food, contact, inhalation, insect venom and occupational allergens are recorded so that healthcare providers can take them into account in a general sense.
  • It is important to share sensitivities with other caregivers of the patient so that they too can provide care in a safe manner. For that purpose, it is possible to record and exchange additional information so that the receiving party can appreciate the hypersensitivity. For example, by describing the method of determination, and also a description of (a) reaction(s) to the substance.
  • A (drug) hypersensitivity is not the same as a problem or episode. That's because a hypersensitivity is captured specifically from the context of surveillance. A (drug) hypersensitivity is therefore not recorded in the context of diagnostics or in the context of treatment of a (drug) hypersensitivity.

Evidence Base

  • In order to be able to register and handle hypersensitivities in the work process of prescribers and pharmacists (in pharmacovigilance), the available codings in the G-standard and SHB are used for medicines in the Netherlands. The working method is laid down in the agreement set Registration and transfer of drug hypersensitivities.
  • For hypersensitivity to food, articles (such as bandages and plasters), plants and animals, five reference lists based on SNOMED CT containing food allergens, inhalation allergens, insect venom allergens, occupational allergens and contact allergens are used. Free text is also possible.

Information Model


Reaction-v1.0(2022EN)HealthProfessional-v3.5.2(2022EN)#WayOfDeterminationCodelist#2357#2350#2329#2351#AgentHPKCodelist#AgentAllergicAgentCodelist#AgentThesaurus122Codelist#AgentSNKCodelist#AgentSSKCodelist#2349#2347#2363#HypersensitivityStatusCodelist#HypersensitivityCategoryCodelist#CriticalExtentCodelist#2356#2361#2360#2359#2348Hypersensitivity-v1.0Model(2022EN).png


Type Id Concept Card. Definition DefinitionCode Reference
Block.png NL-CM:8.4.1 Arrowdown.pngHypersensitivity Root concept of the Hypersensitivity information model. This root concept contains all data elements of the Hypersensitivity information model.
Verwijzing.png NL-CM:8.4.2 Arrowright.pngReaction 0..* Root concept of the Reaction information model. This root concept contains all data elements of the Reaction information model.
Block.png Reaction
TS.png NL-CM:8.4.3 Arrowright.pngDateTimeClosure 0..1 The date and time when it was decided to stop monitoring.​
Verwijzing.png NL-CM:8.4.4 Arrowright.pngFirstAuthor::HealthProfessional 1 The healthcare professional who first started monitoring the hypersensitivity.
Block.png HealthProfessional
CD.png NL-CM:8.4.5 Arrowright.pngWayOfDetermination 0..1 The way in which the hypersensitivity is determined.
List2.png WayOfDeterminationCodelist
ST.png NL-CM:8.4.6 Arrowright.pngSourceDescription 0..1 The description of how the information was obtained, such as receiving a letter from a specialist or an interview with the patient.
ST.png NL-CM:8.4.7 Arrowright.pngReasonForClosure 0..1 Reason why the hypersensitivity is closed.
CD.png NL-CM:8.4.8 Arrowright.pngAgent 1 The substance or group of substances that is monitored.
List2.png AgentAllergicAgentCodelist
List2.png AgentHPKCodelist
List2.png AgentSNKCodelist
List2.png AgentSSKCodelist
List2.png AgentThesaurus122Codelist
CD.png NL-CM:8.4.9 Arrowright.pngHypersensitivityCategory 0..* Identifies the hypersensitivity category such as medication, food or environment.
List2.png HypersensitivityCategoryCodelist
CD.png NL-CM:8.4.10 Arrowright.pngHypersensitivityStatus 0..1 Statement on the status of the patient’s hypersensitivity.
List2.png HypersensitivityStatusCodelist
TS.png NL-CM:8.4.11 Arrowright.pngStartDateTime 0..1 Date and time when the hypersensitivity first manifested itself in a reaction. This can be an exact date and time, but also a global indication of the date (for example, only year or year and month).
CD.png NL-CM:8.4.12 Arrowright.pngCriticality 1 The healthcare professional's assessment of whether the hypersensitivity is a contraindication to intended or unintended exposure to the substance, group of substances or environmental factor to which the patient is hypersensitive.
246112005 Severity
List2.png CriticalExtentCodelist
TS.png NL-CM:8.4.13 Arrowright.pngStartSurveillanceDateTime 1 Date and time when the first author started monitoring the hypersensitivity.
ST.png NL-CM:8.4.14 Arrowright.pngComment 0..1 Textual explanation of the hypersensitivity which cannot be entered in any of the other fields.
48767-8 Annotation comment [Interpretation] Narrative

Columns Concept and DefinitionCode: hover over the values for more information
For explanation of the symbols, please see the legend page List2.png

Example Instances

Only available in Dutch

Voorbeeld file fout: Unable to find the specified file. : nl.zorg.Overgevoeligheid-v1.0(NL)_Voorbeeld.docx

Issues

No known allergies The question is whether to offer a code for "No known allergies (SNOMED CT 160244002)" and subdirectories in this information model that fall under this code, or to determine that, where applicable, the document should outline when the information model is to be applied.
Value set for the ‘Causative substance’ concept Currently, no defined code list is yet available for allergenic substances other than medication. Entering SNOMED CT must therefore suffice to code allergenic substances for the time-being. The G standard is used to code medical products.

References

1. Z-INDEX. (2011) Allergieën en ongewenste middelen [Online] v. R V-2-3-1 Beschikbaar op: http://www.z-index.nl/g-standaard/beschrijvingen/functioneel/wijzigingen/mb/bewaking-op-allergie/IR%20Allergieen%20V%202-1-1.pdf [Geraadpleegd: 15 oktober 2014]

2. HL7 FHIR Resource AllergyIntolerance. [Online] Continuous Build. Beschikbaar op: http://hl7-fhir.github.io/allergyintolerance.html [Geraadpleegd: 12 maart 2014]

Valuesets

AgentAllergicAgentCodelist

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.8.4.2 Binding: Required
Conceptname Codesystem name Codesystem OID
SNOMED CT: ^98061000146100|Dutch total non-drug allergen simple reference set| SNOMED CT 2.16.840.1.113883.6.96

AgentHPKCodelist

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.8.4.3 Binding: Required
Conceptname Codesystem name Codesystem OID
All values G-Standaard Handels Product Kode (HPK) 2.16.840.1.113883.2.4.4.7

AgentSNKCodelist

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.8.4.4 Binding: Required
Conceptname Codesystem name Codesystem OID
All values G-standaard Stofnaamcode (SNK) 2.16.840.1.113883.2.4.4.1.750

AgentSSKCodelist

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.8.4.5 Binding: Required
Conceptname Codesystem name Codesystem OID
All values G-standaard Stofnaamcode i.c.m. toedieningsweg (SSK) 2.16.840.1.113883.2.4.4.1.725

AgentThesaurus122Codelist

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.8.4.6 Binding: Required
Conceptname Codesystem name Codesystem OID
All values G-standaard Ongewenste medicatiegroepen 2.16.840.1.113883.2.4.4.1.902.122

CriticalExtentCodelist

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.8.4.9 Binding: Required
Conceptname Conceptcode Codesystem name Codesystem OID Description
Mild 255604002 SNOMED CT 2.16.840.1.113883.6.96 Laag
Severe 24484000 SNOMED CT 2.16.840.1.113883.6.96 Hoog
Geen oordeel NTB SNOMED CT 2.16.840.1.113883.6.96 Geen oordeel

HypersensitivityCategoryCodelist

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.8.4.7 Binding: Required
Conceptname Conceptcode Codesystem name Codesystem OID Description
Propensity to adverse reactions to food 418471000 SNOMED CT 2.16.840.1.113883.6.96 Voedselallergeen
Propensity to adverse reactions to drug 419511003 SNOMED CT 2.16.840.1.113883.6.96 Geneesmiddel
Propensity to adverse reaction to occupational allergen 157541000146109 SNOMED CT 2.16.840.1.113883.6.96 Beroepsallergeen
Propensity to adverse reaction to inhalation allergen 157521000146103 SNOMED CT 2.16.840.1.113883.6.96 Inhalatieallergeen
Propensity to adverse reaction to contact allergen 157531000146101 SNOMED CT 2.16.840.1.113883.6.96 Contactallergeen
Propensity to adverse reaction to insect venom 157511000146108 SNOMED CT 2.16.840.1.113883.6.96 Insectengifallergeen

HypersensitivityStatusCodelist

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.8.4.8 Binding: Required
Conceptname Conceptcode Codesystem name Codesystem OID Description
Active 55561003 SNOMED CT 2.16.840.1.113883.6.96 Actief
Inactive 73425007 SNOMED CT 2.16.840.1.113883.6.96 Inactief

WayOfDeterminationCodelist

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.8.4.1 Binding: Extensible
Conceptname Conceptcode Codesystem name Codesystem OID Description
Vastgesteld op basis van het klinisch beeld en aanvullend onderzoek NTB SNOMED CT 2.16.840.1.113883.6.96 Vastgesteld op basis van het klinisch beeld en aanvullend onderzoek
Vastgesteld op basis van het klinisch beeld NTB SNOMED CT 2.16.840.1.113883.6.96 Vastgesteld op basis van het klinisch beeld
Op basis van de anamnese NTB SNOMED CT 2.16.840.1.113883.6.96 Op basis van de anamnese

This information model in other releases

Information model references

This information model refers to

This information model is used in

--

Technical specifications in HL7v3 CDA and HL7 FHIR

To exchange information based on health and care information models, additional, more technical specifications are required.<BR> Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:

  • HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment Artdecor.jpg
  • HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR Fhir.png

Downloads

This information model is also available as pdf file PDF.png or as spreadsheet Xlsx.png

About this information

The information in this wikipage is based on Pre-release 2022-1
SNOMED CT and LOINC codes are based on:

  • SNOMED Clinical Terms versie: 20230930 [R] (september 2023-editie)
  • LOINC version 2.76

Conditions for use are located on the mainpage List2.png
This page is generated on 27/03/2024 11:10:39 with ZibExtraction v. 9.3.8851.20230

Back 16.png Back to HCIM list
Overgenomen van "https://zibs.test-nictiz.nl/index.php?title=Hypersensitivity-v1.0(2022EN)&oldid=27852"